Anticancer agents targeting signaling molecules and cancer cell environment: Challenges for drug development

Journal of the National Cancer Institute

Volumn 91, Issue 15, 1999, Pages 1281-1287

  Gelmon, K A ^a   Eisenhauer, E A ^a   Harris, A L ^a   Ratain, M J ^a   Workman, P ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TUMOR MARKER;

ASSAY; CANCER SURVIVAL; CYTOTOXICITY; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG SCREENING; GOOD MANUFACTURING PRACTICE; HEALTH ECONOMICS; MAXIMUM PERMISSIBLE DOSE; METASTASIS; NOTE; PHARMACODYNAMICS; PRIORITY JOURNAL; QUALITY OF LIFE; TUMOR CELL CULTURE;

EID: 0033523233     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.15.1281     Document Type: Note

References (48)